Isoflurane post-treatment ameliorates GMH-induced brain injury in neonatal rats

Stroke. 2013 Dec;44(12):3587-90. doi: 10.1161/STROKEAHA.113.001988. Epub 2013 Oct 22.

Abstract

Background and purpose: This study investigated whether isoflurane ameliorates neurological sequelae after germinal matrix hemorrhage (GMH) through activation of the cytoprotective sphingosine kinase/sphingosine-1-phosphate receptor/Akt pathway.

Methods: GMH was induced in P7 rat pups by intraparenchymal infusion of bacterial collagenase (0.3 U) into the right hemispheric germinal matrix. GMH animals received 2% isoflurane either once 1 hour after surgery or every 12 hours for 3 days. Isoflurane treatment was then combined with sphingosine-1-phosphate receptor-1/2 antagonist VPC23019 or sphingosine kinase 1/2 antagonist N,N-dimethylsphingosine.

Results: Brain protein expression of sphingosine kinase-1 and phosphorylated Akt were significantly increased after isoflurane post-treatment, and cleaved caspase-3 was decreased at 24 hours after surgery, which was reversed by the antagonists. Isoflurane significantly reduced posthemorrhagic ventricular dilation and improved motor, but not cognitive, functions in GMH animals 3 weeks after surgery; no improvements were observed after VPC23019 administration.

Conclusions: Isoflurane post-treatment improved the neurological sequelae after GMH possibly by activation of the sphingosine kinase/Akt pathway.

Keywords: apoptosis; caspase-3; isoflurane; sphingosine kinase.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Animals, Newborn
  • Brain / drug effects*
  • Brain / metabolism
  • Disease Models, Animal
  • Intracranial Hemorrhages / chemically induced
  • Intracranial Hemorrhages / drug therapy*
  • Intracranial Hemorrhages / metabolism
  • Isoflurane / pharmacology
  • Isoflurane / therapeutic use*
  • Neuroprotective Agents / pharmacology
  • Neuroprotective Agents / therapeutic use*
  • Phosphorylation / drug effects
  • Phosphotransferases (Alcohol Group Acceptor) / metabolism
  • Proto-Oncogene Proteins c-akt / metabolism
  • Rats
  • Receptors, Lysosphingolipid / metabolism
  • Recovery of Function / drug effects
  • Signal Transduction / drug effects
  • Sphingosine / analogs & derivatives
  • Sphingosine / pharmacology
  • Sphingosine / therapeutic use

Substances

  • Neuroprotective Agents
  • Receptors, Lysosphingolipid
  • Isoflurane
  • Phosphotransferases (Alcohol Group Acceptor)
  • sphingosine kinase
  • Proto-Oncogene Proteins c-akt
  • N,N-dimethylsphingosine
  • Sphingosine